Evaluating the ability of some natural phenolic acids to target the main protease and AAK1 in SARS COV-2

Sci Rep. 2023 May 5;13(1):7357. doi: 10.1038/s41598-023-34189-6.

Abstract

Researchers are constantly searching for drugs to combat the coronavirus pandemic caused by SARS-CoV-2, which has lasted for over two years. Natural compounds such as phenolic acids are being tested against Mpro and AAK1, which are key players in the SARS-CoV-2 life cycle. This research work aims to study the ability of a panel of natural phenolic acids to inhibit the virus's multiplication directly through Mpro and indirectly by affecting the adaptor-associated protein kinase-1 (AAK1). Pharmacophore mapping, molecular docking, and dynamic studies were conducted over 50 ns and 100 ns on a panel of 39 natural phenolic acids. Rosmarinic acid (16) on the Mpro receptor (- 16.33 kcal/mol) and tannic acid (17) on the AAK1 receptor (- 17.15 kcal/mol) exhibited the best docking energy against both receptors. These favourable docking score values were found to be superior to those of the co-crystallized ligands. Preclinical and clinical research is required before using them simultaneously to halt the COVID-19 life cycle in a synergistic manner.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adaptor Proteins, Signal Transducing
  • COVID-19*
  • Coronavirus 3C Proteases*
  • Humans
  • Molecular Docking Simulation
  • Molecular Dynamics Simulation
  • Oligonucleotides
  • Protease Inhibitors*
  • SARS-CoV-2

Substances

  • AAK1 protein, human
  • Adaptor Proteins, Signal Transducing
  • Oligonucleotides
  • phenolic acid
  • Protease Inhibitors
  • 3C-like proteinase, SARS-CoV-2
  • Coronavirus 3C Proteases